Acutus Medical Inc AFIB shares are trading lower by 20.8% at $1.53 after the company reported worse-than-expected fourth-quarter EPS results and issued first-quarter sales guidance below analyst estimates.
Acutus Medical reported quarterly losses of $1.00 per share which missed the analyst consensus estimate of a loss of 83 cents per share. Acutus Medical reported quarterly sales of $4.36 million which beat the analyst consensus estimate of $4.21 million by 3.6%. This is a 69% increase over sales of $2.57 million in the same period last year.
Acutus Medical also sees first-quarter 2022 revenue as low as $3.2 million or as high as $3.5 million, which is below the analyst consensus estimate of $4.51 million.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.